Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cantor Fitzgerald Maintains Neutral on Humana, Lowers Price Target to $360

Author: Benzinga Newsdesk | April 25, 2024 10:42am
Cantor Fitzgerald analyst Sarah James maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $391 to $360.

Posted In: HUM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist